ES2176322T3 - Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion. - Google Patents

Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion.

Info

Publication number
ES2176322T3
ES2176322T3 ES95910838T ES95910838T ES2176322T3 ES 2176322 T3 ES2176322 T3 ES 2176322T3 ES 95910838 T ES95910838 T ES 95910838T ES 95910838 T ES95910838 T ES 95910838T ES 2176322 T3 ES2176322 T3 ES 2176322T3
Authority
ES
Spain
Prior art keywords
peptides
pain
treatment
opioid
opioid peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95910838T
Other languages
English (en)
Inventor
William Brown
John Dimaio
Peter Schiller
Rene Martel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403263A external-priority patent/GB9403263D0/en
Priority claimed from SE9401519A external-priority patent/SE9401519D0/xx
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Application granted granted Critical
Publication of ES2176322T3 publication Critical patent/ES2176322T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SERIE DE NUEVOS PEPTIDOS OPIOIDE PARA EL TRATAMIENTO DEL DOLOR Y COMPOSICIONES FARMACEUTICAMENTE ACEPTABLES QUE CONTIENEN DICHOS PEPTIDOS.LA INVENCION TAMBIEN ENSEÑA METODOS PARA CONTROLAR EL DOLOR EN PACIENTES USANDO LAS COMPOSICIONES DE LA INVENCION.LOS PEPTIDOS DE LA INVENCION TIENEN UN ALTO GRADO DE SELECTIVIDAD PARA LOS RECEPTORES {MU}-OPIOIDE. ESTOS PEPTIDOS SON ALTAMENTE LIPOFILICOS.A PESAR DE SU CARACTER LIPOFILICO, NO ATRAVIESAN LA BARRERA DE SANGRE DEL CEREBRO (BBB).LOS PEPTIDOS DE LA INVENCION ESTAN PARTICULARMENTE BIEN PREPARADOS COMO AGENTES ANALGESICOS ACTUANDO SUBSTANCIALMENTE SOBRE LOS RECEPTORES {MU}-OPIOIDE PERIFERICOS, DEBIDO A QUE ESTOS PEPTIDOS ACTUAN PERIFERICAMENTE, EVITAN LA PRODUCCION DE EFECTOS LATERALES NORMALMENTE ASOCIADOS CON LA ACCION ANALGESICA CENTRAL.
ES95910838T 1994-02-21 1995-02-15 Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion. Expired - Lifetime ES2176322T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9403263A GB9403263D0 (en) 1994-02-21 1994-02-21 Novel opiod peptides
GB9408179A GB9408179D0 (en) 1994-02-21 1994-04-25 Novel opioid peptides for the treatment of pain and use thereof
SE9401519A SE9401519D0 (sv) 1994-05-03 1994-05-03 Novel opioid peptides for the tratment of pain and use thereof

Publications (1)

Publication Number Publication Date
ES2176322T3 true ES2176322T3 (es) 2002-12-01

Family

ID=27267061

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95910838T Expired - Lifetime ES2176322T3 (es) 1994-02-21 1995-02-15 Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion.

Country Status (20)

Country Link
EP (1) EP0746567B1 (es)
JP (1) JPH09509168A (es)
AT (1) ATE217011T1 (es)
BR (1) BR9506847A (es)
CA (1) CA2181367A1 (es)
CZ (1) CZ288523B6 (es)
DE (1) DE69526577T2 (es)
EE (1) EE03265B1 (es)
ES (1) ES2176322T3 (es)
FI (1) FI963252A (es)
HR (1) HRP950413A2 (es)
HU (1) HUT74731A (es)
IS (1) IS4261A (es)
MX (1) MX9603489A (es)
NO (1) NO963464L (es)
NZ (1) NZ281742A (es)
PL (1) PL181092B1 (es)
SK (1) SK93596A3 (es)
TW (1) TW408131B (es)
WO (1) WO1995022557A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9503924D0 (sv) 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
CA2223428A1 (en) * 1995-06-07 1996-12-19 Torrey Pines Institute For Molecular Studies Novel mu opioid receptor ligands: agonists and antagonists
GB9516994D0 (en) * 1995-08-18 1995-10-18 Iaf Biochem Int Solution synthesis of peripheral acting analgestic opioid tetrapeptides
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
US5885958A (en) * 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
WO1999065932A1 (en) * 1998-06-18 1999-12-23 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
AU2001239896A1 (en) 2000-03-16 2001-10-03 Sepracor, Inc. Peptidomimetic ligands for cellular receptors and ion channels
WO2002005748A2 (en) * 2000-07-18 2002-01-24 Cornell Research Foundation, Inc. Medicinal uses of mu-opioid receptor agonists
AU2004209663B2 (en) 2003-02-04 2009-01-15 Clinical Research Institute Of Montreal Methods for preventing mitochondrial permeability transition
EP2604621B1 (en) 2003-05-01 2015-10-21 Cornell Research Foundation, Inc. Method and carrier complexes for delivering molecules to cells
CA2971931C (en) 2004-01-23 2019-01-08 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
BRPI0609879A2 (pt) 2005-04-28 2010-05-11 Pfizer Ltd derivados de aminoácidos
US7541340B2 (en) 2005-09-16 2009-06-02 Cornell Research Foundation, Inc. Methods for reducing CD36 expression
EP1782819A1 (en) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
MY148144A (en) 2006-11-10 2013-03-15 Cara Therapeutics Inc Synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
CN102127151B (zh) * 2007-06-11 2012-07-04 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN102127152B (zh) * 2007-06-11 2012-07-04 北京大学 一种抗阿片肽的拮抗肽与该拮抗肽的应用
CN101805396B (zh) * 2007-06-28 2011-09-14 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN101817877B (zh) * 2007-06-28 2011-09-14 北京大学 一种抗阿片肽的活性片段
WO2009100363A2 (en) 2008-02-07 2009-08-13 Cornell University Methods for preventing or treating insulin resistance
CN101951936A (zh) 2008-02-26 2011-01-19 康奈尔大学 用于防止和治疗急性肾损伤的方法
CN112469729A (zh) * 2018-05-31 2021-03-09 悉尼大学 镇痛剂及其使用方法
JP7437578B2 (ja) * 2019-03-20 2024-02-26 国立大学法人東北大学 新規オピオイドペプチド、その糖鎖付加体及びそれらを含む医薬組成物
CN113968902B (zh) * 2020-07-25 2023-05-26 兰州大学 亮氨酸-脑啡肽类似物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
ATE235911T1 (de) * 1992-11-12 2003-04-15 Sod Conseils Rech Applic Opioidpeptide
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides

Also Published As

Publication number Publication date
CA2181367A1 (en) 1995-08-24
FI963252A0 (fi) 1996-08-20
ATE217011T1 (de) 2002-05-15
BR9506847A (pt) 1997-09-30
SK93596A3 (en) 1997-05-07
WO1995022557A1 (en) 1995-08-24
JPH09509168A (ja) 1997-09-16
HUT74731A (en) 1997-02-28
HU9602281D0 (en) 1996-10-28
NZ281742A (en) 1997-06-24
AU690648B2 (en) 1998-04-30
TW408131B (en) 2000-10-11
EP0746567B1 (en) 2002-05-02
MX9603489A (es) 1997-03-29
FI963252A (fi) 1996-08-20
DE69526577T2 (de) 2003-01-02
NO963464L (no) 1996-08-20
HRP950413A2 (en) 1997-10-31
EP0746567A1 (en) 1996-12-11
EE03265B1 (et) 2000-04-17
CZ288523B6 (cs) 2001-07-11
IS4261A (is) 1995-08-22
PL315947A1 (en) 1996-12-09
DE69526577D1 (de) 2002-06-06
AU1865195A (en) 1995-09-04
PL181092B1 (pl) 2001-05-31
CZ239196A3 (en) 1996-12-11

Similar Documents

Publication Publication Date Title
ES2176322T3 (es) Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion.
SE9503924D0 (sv) Novel opioid peptides
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
BRPI9708566A (pt) Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2.
ES2096312T3 (es) Derivado de quinuclidina como antagonista de la sustancia p.
BG103521A (en) Substituted pyrimidinon and pyridon compounds and methods for their application
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
HUP0301920A2 (hu) P anyag receptor antagonista és magnézium vegyület kombinációját tartalmazó agy-, gerinc- és idegsérülés kezelésére szolgáló injekciós készítmény
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
ES2194392T3 (es) Derivados alfa-aminoamidicos utiles como agentes analgesicos.
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
BRPI0408601A (pt) compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu uso
BG103512A (en) Substituted pyramidine compounds and their application
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
EP1164141A3 (en) Opioid peptides and their use for treatment of pain
WO1995000154B1 (en) Antidepressant agents with a rapid onset of action
YU24603A (sh) Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin
SE9502877D0 (sv) Novel opioid peptides
BR0016720A (pt) Uso de trimebutina para tratamento de dores
TR199901385T2 (xx) Piperidin t�revleri.
ES2188232T3 (es) Uso de cetirizina para impedir la aparicion del asma.
YU55095A (sh) Novi opioidni peptidi za lečenje bola i njihova primena novel
RU97112616A (ru) Лекарственный препарат для лечения проктологических заболеваний